Conference Schedule
Day1: April 22, 2019
Keynote Forum
Narendra Kumar Chopra
SEGi University, Malaysia
Title: Past, present and future status of HIV/AIDS Global pandemic problem in world
10:10-10:50
Biography
Abstract
Tracks
- Respiratory and Pulmonary infectious diseases | Infectious Diseases Epidemiology | Infection and Immune System | Vaccine and Vaccination | Zika/Ebola viruses
Location: Olimpica 2-20 Theater
Zlata Rasulzade
Republican Anti-Plaque Station, Azerbaijan
Chair
Zlata Rasulzade
Republican Anti-Plaque Station, Azerbaijan
Title: Enhancement of disease reporting after implementation of the electronic integrated disease surveillance system in Azerbaijan
10:50-11:20
Biography
Abstract
Serdal Arslan
Sivas Cumhuriyet University, Turkey
Title: Investigation of Long NoncodingRNA (lncRNA) in Crimean-Congo Hemorrhagic Fever patients
11:40-12:10
Biography
Abstract
Ishag Adam
University of Khartoum, Sudan
Title: Association between placental submicroscopic Plasmodium falciparum malaria, Helicobacter pylori and low birth weight
12:10-12:40
Biography
Abstract
Josef Soukup
Czech University of Life Sciences, Czech Republic
Title: Plant oils rich in medium-chain fatty acids inhibit the efficacy of antibiotics
12:40-13:10
Biography
Abstract
Adriana Calderaro
University of Parma, Italy
Title: Conventional methods, molecular assays and MALDI-TOF MS as combined tools in diagnostic parasitology
14:20-14:50
Biography
Abstract
Ishag Adam
University of Khartoum, Sudan
Title: Malaria in pregnancy: Maternal, perinatal adverse effects and management
14:50-15:20
Biography
Abstract
Marina Papaianni
University of Naples Federico II, Italy
Title: Phage therapy: A crosslink between human and plants bacterial infection
15:20-16:00
Biography
Abstract
16:00-16:30
Biography
Abstract
Day2: April 23, 2019
Keynote Forum
Tracks
- Poster presentations
Location: Foyer
Zlata Rasulzade
Republican Anti-Plaque Station, Azerbaijan
Chair
Sabina Ibrahimova
Republican Anti-Plaque Station, Azerbaijan
Title: Assessment the prevalence of highly pathogenic bunyavirus (Crimean-Congo Hemorrhagic Fever Virus) circulating in Azerbaijan
11:00-12:00
Biography
Abstract
Crimean-Congo Hemorrhagic Fever is a tick-borne zoonotic disease caused by single strained RNA virus belonging to the ecological group of arboviruses (the genus Nairovirus of the family Bunyaviridae) carriedvby Ixodes ticks. The virus is highly pathogenic in nature, easily transmissible and has a high case fatality rate of 10-40%. Knowledge for the prevalence of Crimean-Congo Hemorrhagic Fever virus (CCHFV), especially its seasonal and ecological changes is fragmentary in Azerbaijan. The urgency of the problem is also related to the sporadic or outbreak character of the epidemic of the CCHF disease in neighboring countries (Iran, Turkey, Georgia), which determines the need to study the epidemiological aspect of the CCHFV in Azerbaijan. The aim of this study was to give a description of the circulation of the CCHFV in Azerbaijan and to identify the possibility of CCHF virusspecific antibodies among patients with unexplained etiology and with the following clinical symptoms: temperature, nausea, headache, myalgia, etc. During the ELISA training carried out by the Public Health of England (PHE) in RAPS, Baku, Azerbaijan in August 2017, the researchers from UK PHE and RAPS screened 400 human serum samples that had been collected previously for testing against Brucella spp. antibodies in the frame of the Brucella active surveillance program in Azerbaijan in 2016-2017. Collected serum samples were stored at -20°C. The vector-best CCHF IgG ELISA kits were used for testing of samples on a Thermo Scientific Multiskan FC microbiological analyzer. The antibodies against CCHFV were detected in 100 samples (25%) and the interesting fact that 21 out of 100 samples were from the people that have been diagnosed with brucellosis. We recommend testing all samples received in the frame of the Brucella active surveillance program using two complementary methods like determination of antibodies against the CCHFV by ELISA and detection of RNA of the CCHFV by PCR. Application of the PCR assay shows no cross reactivity and does not detect other viruses from within the same genus. Usage of the molecular based assays is necessary for the definition of the CCHFV strain circulating in Azerbaijan.
Chichak Sulrymanova
Azerbaijan Food Safety Institute, Azerbaijan
Title: Study of rabies virus circulating in Azerbaijan
11:00-12:00
Biography
Abstract
Rabies is estimated to cause at least 55,000 deaths per year worldwide. Azerbaijan is located in the South Caucasus, a region of geopolitical importance located at the gateway between Europe and Asia. This geographical location makes the region of central importance to epidemiological study and the control of transboundary infectious diseases such as rabies. According to reports from the Azerbaijan State Veterinary Control Service, rabies cases are observed among animals and fatal cases occur sporadically among people in Azerbaijan annually. However, despite all the research conducted, there is still a lack of information regarding the circulation of rabies in Azerbaijan. Therefore, the goal of this study is the continuing study of rabies positive samples for further identification of the circulation of the virus in Azerbaijan in order to plan a vaccination program. The statistical information regarding rabies cases in animals 2016 – 2017 was collected from the Azerbaijan State Veterinary Control Service. The National Reference Laboratoryunder the Food Safety Institute (FSI) tested the collected samples. A total of 48 animals tested positive for rabies (18 domestic and 3 stray dogs, 17 cattle, 1 donkey, 5 catsand 3 jackals) from 26 villages in Azerbaijan in 2016. In 2017, 73 animals (17 domestic and 14 stray dogs, 32 cattle, 2 small ruminants, 1 horse, 1 donkey, 2 cats, 1 wolf and 3 jackals) tested positive from 33 villages in Azerbaijan. The results were mapped to identify the rabies foci. The samples confirmed as positive were officially transferred to the FSI in triple packages following BS&S guidance. These strains were stored in a BSL-2 laboratory freezer at -80ºC at the Azerbaijan FSI. The work on the stored samples will commence in November 2018. A PCR analysis will be conducted on the 12 stored positive samples. Afterwards, samples confirmed as positive will be sequenced with the help of the OIE Veterinary Control Central Research Institute in Ankara in 2019. This laboratory provided training on rabies diagnosis to the research team participants in 2017.